The Role of Intermediaries in Connecting Individuals to Local Physical Activity - Study Protocol (NCT06260995) | Clinical Trial Compass
CompletedNot Applicable
The Role of Intermediaries in Connecting Individuals to Local Physical Activity - Study Protocol
Ireland30 participantsStarted 2023-09-01
Plain-language summary
Intermediaries help people to connect to community-based services and supports, including physical activity and exercise groups (physical activities). They do this by acting as a link person. After receiving a referral or self-referral, they conduct an assessment, connect people to services in the community, and follow-up with people over time.
This project will investigate if connecting to physical activities through an intermediary can improve health and wellbeing. It will also investigate people's experiences of working with an intermediary. This project is a pilot feasibility study, which means the investigators are evaluating the measures used and the way the trial is designed to see if they are suitable for a larger study in the future.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
* Aged ≥18 years
* Referred to intermediary service for any reason OR self-referred to intermediary service for any reason
* Meets the eligibility criteria of the intermediary service
* Intermediary facilitates a connection to local physical activity
Exclusion criteria
* Non-community dwelling e.g., hospital in-patients, living in residential care facilities
* Diagnosis of dementia
* Inappropriate for health or social reasons (such as terminal illness, family or other social crisis)
* Refused to engage with the intermediary service
* Unable to give explicit informed consent
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
International Physical Activity Questionnaire - Short Form
Timeframe: At baseline (T0) and at the 12-week follow-up assessment (T1)
2
Self-Efficacy for Exercise Scale
Timeframe: At baseline (T0) and at the 12-week follow-up assessment (T1)
3
Short Warwick Edinburgh Mental Well-being Scale
Timeframe: At baseline (T0) and at the 12-week follow-up assessment (T1)